Drive Health Secures $15M Strategic Investment to Expand AI-Powered Clinical Platform Avery

Why It Matters

The capital infusion enables Drive Health to deepen EHR integrations and scale AI‑driven care coordination, addressing clinician staffing shortages and improving patient engagement across health systems.

Key Takeaways

• Drive Health secured $15M to scale Avery AI platform.
• Avery supports patient communication in over 15 languages.
• Funding fuels EHR integration and new care pathway development.
• Vitalis joins board, adding operational health‑system expertise.
• Avery will serve 56,000 families in Illinois Healthy Baby.

Pulse Analysis

AI‑driven workflow automation is reshaping hospital operations, and Drive Health’s Avery platform sits at the intersection of scalability and clinical safety. Built on Google Cloud, Avery leverages natural‑language processing to handle discharge planning, secure‑message triage, and follow‑up across multilingual populations. By automating routine interactions, the platform frees nursing staff to focus on complex care, directly tackling the chronic labor shortages that have plagued U.S. health systems for years.

The $15 million infusion, led by Vitalis Ventures, not only expands Drive Health’s financial runway but also brings strategic board expertise that can accelerate nationwide deployments. The capital will fund deeper integrations with electronic health‑record systems, broaden language support beyond the current 15 languages, and enable new care pathways such as chronic disease management and maternal health. Participation in Illinois’ Healthy Baby initiative showcases a real‑world use case, delivering reminders and symptom checks to over 56,000 families while leveraging Google Pixel devices and Fitbit wearables.

Beyond immediate product enhancements, the round signals growing investor confidence in regulated AI‑assisted care coordination. With a Clinical Advisory Council and Safety Committee overseeing governance, Avery maintains a human‑in‑the‑loop model that aligns with emerging FDA and international AI guidelines. As health systems seek cost‑effective solutions to reduce administrative burden, platforms like Avery are poised to become essential infrastructure, potentially redefining how patient communication and follow‑up are managed at scale.

Deal Summary

Drive Health announced a $15 million strategic investment led by Vitalis Ventures with co‑investor Inside Capital Partners to scale its Google‑powered clinical workflow AI platform, Avery. The funding will support product expansion, multilingual capabilities, and preparation for a Series A round in 2026.